|
⚲
|
| Keyboard |
| Jason Leverone | |
|---|---|
| Firm | |
| Address | c/o Onkure Therapeutics, Inc 6707 Winchester Circle, Suite 400 Boulder, CO 80301 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Onkure Therapeutics Inc | 021-527340 | Executive Officer | 65.0 M of 65.0 M |
||
| Onkure Inc | 021-477677 | Executive Officer | 53.8 M of 60.0 M |
||
| Onkure Inc | 021-391328 | Executive Officer | 56.6 M of 56.6 M |
||
| Miragen Therapeutics Inc | 021-379997 | Executive Officer | 91.0 M of 91.0 M |
||
| Miragen Therapeutics Inc | 021-318573 | Executive Officer | 1.5 M of 5.0 M |
||
| Miragen Therapeutics Inc | 021-299421 | Executive Officer | 0.2 M of 0.2 M |
||
| Miragen Therapeutics Inc | 021-280608 | Executive Officer | 40.7 M of 40.7 M |
||
| Miragen Therapeutics Inc | 021-251118 | Executive Officer | 25.0 M of 41.1 M |
||
| Miragen Therapeutics Inc | 021-234182 | Executive Officer | 8.5 M of 20.0 M |
||
| Miragen Therapeutics Inc | 021-177167 | Executive Officer | 13.0 M of 20.0 M |
||
| Miragen Therapeutics Inc | 021-148007 | Executive Officer | 6.0 M of 6.0 M |
||